From €2507EUR$2,595USD£2,143GBP
- Report
- December 2023
- 80 Pages
South Korea
From €2507EUR$2,595USD£2,143GBP
- Report
- December 2023
- 80 Pages
Saudi Arabia
From €2507EUR$2,595USD£2,143GBP
- Report
- December 2023
- 80 Pages
Russia
From €2507EUR$2,595USD£2,143GBP
- Report
- December 2023
- 80 Pages
Poland
From €2507EUR$2,595USD£2,143GBP
- Report
- December 2023
- 80 Pages
Japan
From €2507EUR$2,595USD£2,143GBP
- Report
- December 2023
- 80 Pages
Ireland
From €2507EUR$2,595USD£2,143GBP
- Report
- December 2023
- 80 Pages
India
From €2507EUR$2,595USD£2,143GBP
- Report
- December 2023
- 80 Pages
Germany
From €2507EUR$2,595USD£2,143GBP
- Report
- December 2023
- 80 Pages
France
From €2507EUR$2,595USD£2,143GBP
- Report
- December 2023
- 80 Pages
China
From €2507EUR$2,595USD£2,143GBP
- Report
- October 2023
- 80 Pages
United Kingdom
From €2507EUR$2,595USD£2,143GBP
From €2507EUR$2,595USD£2,143GBP
- Report
- October 2023
- 80 Pages
South Korea
From €2507EUR$2,595USD£2,143GBP
- Report
- October 2023
- 80 Pages
Saudi Arabia
From €2507EUR$2,595USD£2,143GBP
- Report
- October 2023
- 80 Pages
India
From €2507EUR$2,595USD£2,143GBP
- Report
- October 2023
- 80 Pages
Germany
From €2507EUR$2,595USD£2,143GBP
- Report
- October 2023
- 80 Pages
France
From €2507EUR$2,595USD£2,143GBP
- Report
- October 2023
- 80 Pages
China
From €2507EUR$2,595USD£2,143GBP
- Report
- November 2023
- 102 Pages
Global
From €3500EUR$3,881USD£3,098GBP
Levothyroxine is a synthetic thyroid hormone used to treat hypothyroidism, a condition in which the thyroid gland does not produce enough thyroid hormone. It is a part of the Endocrine and Metabolic Disorders Drugs market, which includes drugs used to treat a variety of conditions related to hormones and metabolism. These drugs are used to treat conditions such as diabetes, obesity, and thyroid disorders. Levothyroxine is the most commonly prescribed drug in this market, as it is used to treat the most common form of hypothyroidism.
Levothyroxine is available in both generic and brand-name forms. Generic levothyroxine is widely available and is often the preferred option due to its lower cost. Brand-name levothyroxine is more expensive but may be preferred by some patients due to its higher quality.
Some companies in the Levothyroxine market include AbbVie, Mylan, Teva Pharmaceuticals, and Sandoz. Show Less Read more